Proposed Data Collections Submitted for Public Comment and Recommendations, 6009-6011 [05-2144]
Download as PDF
<![CDATA[
Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices
(5) Requester’s specific work
previously performed or currently being
performed, with particular emphasis on
those national programs/projects
dealing with physical activity/fitness,
sports, or other physical activities of a
similar nature, with schools,
organizations, and individuals;
(6) Requester’s personnel: Name,
professional qualifications and specific
experience of key personnel who would
be available to work on these projects;
(7) Requester’s facilities: Availability
and description of facilities required to
administer the program including
information technology, computers,
telecommunication resources;
(8) Requester’s description of
financial management: Discussion of
experience in developing an annual
budget and collecting and managing
monies from organizations and/or
individuals;
(9) Requester’s proposed plan for
managing the PCPFS awards programs,
including such financial aspects as cost
of award materials, promotion,
distribution and program management.
Availability of Funds
There are no Federal funds available
for this cosponsorship.
Dated: January 31, 2005.
Melissa Johnson,
Executive Director, President’s Council on
Physical Fitness and Sports, Department of
Health and Human Services.
[FR Doc. 05–2163 Filed 2–3–05; 8:45 am]
BILLING CODE 4150–35–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Office of the Secretary
Notice of Meeting: Secretary’s
Advisory Committee on Genetics,
Health, and Society
Pursuant to Public Law 92–463,
notice is hereby given of the sixth
meeting of the Secretary’s Advisory
Committee on Genetics, Health, and
Society (SACGHS), U.S. Public Health
Service. The meeting will be held from
8:30 a.m. to 5:30 p.m. on February 28,
2005 and 8:30 a.m. to 5 p.m. on March
1, 2005 at the Bethesda North Marriott
Hotel, 5701 Marinelli Road, North
Bethesda, Maryland. The meeting will
be open to the public with attendance
limited to space available. The meeting
will be webcast.
The meeting is expected to include
presentations and deliberations on
several topics, including the following:
a revised draft report with
recommendations about coverage and
VerDate jul<14>2003
18:52 Feb 03, 2005
Jkt 205001
reimbursement for genetic technologies
and services; current and proposed
efforts to understand gene-environment
interactions through large population
studies; the Committee’s efforts to
explore stakeholder perspectives on the
need for Federal legislation to prevent
genetic discrimination in health
insurance and employment; the
recommendations of the Advisory
Committee on Heritable Disorders and
Genetic Diseases in Newborns and
Children regarding the provision of
screening, counseling and health care
services for newborns and children
having or at risk for heritable disorders;
and efforts to improve the quality of
laboratory testing for rare diseases. Time
will be provided each day for public
comments.
Under authority of 42 U.S.C. 217a,
Section 222 of the Public Health Service
Act, as amended, the Department of
Health and Human Services established
SACGHS to serve as a public forum for
deliberations on the board range of
human health and societal issues raised
by the development and use of genetic
technologies and, as warranted, to
provide advice on these issues. The
draft meeting agenda and other
information about SACGHS, including
information about access to the webcast,
will be available at the following Web
site: https://www4.od.nih.gov/oba/
sacghs.htm.
The Committee would welcome
hearing from anyone wishing to provide
public comment on any issue related to
genetics, health and society. Individuals
who would like to provide public
comment or who plan to attend the
meeting and need special assistance,
such as sign language interpretation or
other reasonable accommodations,
should notify the SACGHS Executive
Secretary, Ms. Sarah Carr, by telephone
at 301–496–9838 or e-mail at
sc112c@nih.gov. The SACGHS office is
located at 6705 Rockledge Drive, Suite
750, Bethesda, MD 20892.
Dated: January 27, 2005.
LaVerne Stringfield,
Director, Office of Federal Advisory
Committee Policy.
[FR Doc. 05–2129 Filed 2–3–05; 8:45 am]
BILLING CODE 4140–01–M
PO 00000
Frm 00047
Fmt 4703
6009
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
[60Day–05–0576]
Proposed Data Collections Submitted
for Public Comment and
Recommendations
In compliance with the requirement
of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for
opportunity for public comment on
proposed data collection projects, the
Centers for Disease Control and
Prevention (CDC) will publish periodic
summaries of proposed projects. To
request more information on the
proposed projects or to obtain a copy of
the data collection plans and
instruments, call the CDC Reports
Clearance Officer on (404) 371–5976.
CDC is requesting an emergency
clearance from OMB regarding this data
collection with a 10 day public
comment period. The emergency
clearance is based on a revision of this
data collection as a result of a final rule.
Comments are invited on: (a) Whether
the proposed collection of information
is necessary for the proper performance
of the functions of the agency, including
whether the information shall have
practical utility; (b) the accuracy of the
agency’s estimate of the burden of the
proposed collection of information; (c)
ways to enhance the quality, utility, and
clarity of the information to be
collected; and (d) ways to minimize the
burden of the collection of information
on respondents, including through the
use of automated collection techniques
or other forms of information
technology. To request a copy of these
requests, call the CDC Reports Clearance
Officer at (404) 371–5976 or send an email to omb@cdc.gov. Written
comments can be sent to Seleda M.
Perryman, CDC Assistant Reports
Clearance Officer, 1600 Clifton Road,
MS–D74, Atlanta, GA 30333 or sent via
e-mail to omb@cdc.gov. Written
comments can also be faxed to the CDC
Desk Officer, Human Resources and
Housing Branch, Office of Management
and Budget at (202) 395–6974. Written
comments should be received within 10
days of this notice.
Proposed Project
Possession, Use, and Transfer of
Select Agents and Toxins (OMB Control
No. 0920–0576)—Extension—Office of
the Director (OD), Centers for Disease
Control and Prevention (CDC).
The Public Health Security and
Bioterrorism Preparedness and
Sfmt 4703
E:\FR\FM\04FEN1.SGM
04FEN1
6010
Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices
Response Act of 2002 (Pub. L. 107–188)
specifies that the Secretary of Health
and Human Services shall provide for
the establishment and enforcement of
standards and procedures governing the
possession, use, and transfer of select
biological agents and toxins. The Act
specifies that facilities that possess, use,
and transfer select agents register with
the Secretary. The Secretary has
designated CDC as the agency
responsible for collecting this
information.
CDC is requesting an emergency
clearance to allow the continued
collection of this information through
the use of five separate forms. These
forms have been revised since the last
clearance. This emergency request will
allow CDC to use the revised forms.
These forms are: (1) Application for
Registration, (2) Transfer of Select Agent
or Toxin Form, (3) Facility Notification
of Theft, Loss, or Release Form, (4)
Clinical and Diagnostic Laboratory
Reporting Form, and (5) Request for
Exemption.
The Application for Registration (42
CFR 73.7(d)) will be used by entities to
register with CDC. The Application for
Registration requests facility
information; a list of select agents or
toxins in use, possession, or for transfer
by the entity; characterization of the
select agent or toxin; and laboratory
information. Estimated average time to
complete this form is 3 hours, 45
minutes for an entity with one principal
investigator working with one select
agent or toxin. CDC estimates that
entities will need an additional 45
minutes for each additional investigator
or agent. In our regulatory analysis, we
have estimated that 70% of the 350
entities have 1–3 principal investigators,
15% have 5 principal investigators, and
15% have 10 principal investigators. We
have used these figures to calculate the
burden for this section. The revisions to
this form were administrative in nature.
Estimated burden for the Application
for Registration is 2,191 hours.
Entities may amend their registration
(42 CFR, 73.7(h)(1)) if any changes occur
in the information submitted to the HHS
Secretary. To apply for an amendment
to a certificate of registration, an entity
must obtain the relevant portion of the
application package and submit the
CFR reference
73.7(d)
73.7(d)
73.7(d)
73.7(d)
18:52 Feb 03, 2005
Number of
respondents
Data collection
...............................................
...............................................
...............................................
...............................................
VerDate jul<14>2003
information requested in the package to
CDC. Estimated time to amend a
registration package is 1 hour.
The Facility Notification Form (42
CFR 73.19(a), (b)) must be completed by
entities whenever there is theft, loss, or
release of a select agent or toxin. In the
revised rules we are now requiring
reporting from exempt entities.
Estimated average time to complete this
form is 1 hour.
The Request for Exemption form (42
CFR 73.5 (d), (e) and 73.6 (d), (e)) will
be used by entities that are using select
agents or toxins in investigational new
drug testing or in cases of public health
emergency. The revisions to this form
were administrative in nature.
Estimated average time to complete this
form is 1 hour.
The Transfer of Select Agent or Toxin
Form (42 CFR 73.16) will be used by
entities requesting transfer of a select
agent or toxin to their facility and by the
entity transferring the agent. CDC
revised the Transfer of Select Agent or
Toxin Form by removing the
requirement that entities provide
written notice within five business days
when select agents or toxins are
consumed or destroyed after a transfer.
Estimated average time to complete this
form is 1 hour, 30 minutes.
The Clinical and Diagnostic
Laboratory Exemption Report (42 CFR
73.5(a), (b) and 73.6(a), (b)) will be used
by clinical and diagnostic laboratories to
notify the HHS Secretary that select
agents or toxins identified as the result
of diagnostic or proficiency testing have
been disposed of in a proper manner. In
the revised form revisions were made to
clarify that the registered entities
required to report can now retain the
agent. Estimated average time to
complete this form is 1 hour.
In addition to the standardized forms,
this regulation also outlines situations
in which an entity must notify or may
make a request of the HHS Secretary in
writing. An entity may apply to the HHS
Secretary for an expedited review of an
individual (e.g. Principal Investigator)
by the Attorney General (42 CFR
73.10(e)). To apply for this expedited
review, an entity must submit a request
in writing to the HHS Secretary
establishing the need for such action.
The estimated time to gather the
information and submit this request is
Registration Application
Additional Investigators
Additional Investigators
Additional Investigators
Jkt 205001
PO 00000
Frm 00048
...................
....................
....................
....................
Fmt 4703
Sfmt 4703
30 minutes. CDC has not developed
standardized forms to use in the above
situations. Rather, the entity should
provide the information as requested in
the appropriate section of the
regulation.
An entity may also apply to the HHS
Secretary for an exclusion of an
attenuated strain of a select agent or
toxin that does not pose a severe threat
to public health and safety (42 CFR
73.3(e)(1) and 73.4(e)(1)). The estimated
time to gather the information and
submit this request is 1 hour.
As part of the requirements of the
Responsible Official, the Responsible
Official is required to conduct regular
inspections (at least annually) of the
laboratory where select agents or toxins
are stored. Results of these selfinspections must be documented (42
CFR 73.9(a)(5)). CDC estimates, that, on
average, such documentation will take 1
hour.
As part of the training requirements of
this regulation, the entity is required to
record the identity of the individual
trained, the date of training, and the
means used to verify that the employee
understood the training (42 CFR
73.15(c)). Estimated time for this
documentation is 2 hours per principal
investigator.
An entity or an individual may
request administrative review of a
decision denying or revoking
certification of registration (42 CFR
73.20). This request must be made in
writing and within 30 calendar days
after the adverse decision. This request
should include a statement of the
factual basis for the review. CDC
estimates the time to prepare and
submit such a request is 4 hours.
Finally, an entity must implement a
system to ensure that certain records
and databases are accurate and that the
authenticity of records may be verified
(42 CFR 73.17). The time to implement
such a system is estimated to average 4
hours.
The cost to respondents is their time
to complete the forms and comply with
the reporting and recordkeeping
components of the Act plus a one-time
purchase of a file cabinet (estimated cost
$400) to maintain records.
Annualized Burden Hours:
Responses
per respondent
350
245
53
52
E:\FR\FM\04FEN1.SGM
1
2
4
9
04FEN1
Average hourly burden
3.75
45/60
45/60
45/60
Total annual
burden
(in hours)
1,313
368
159
351
6011
Federal Register / Vol. 70, No. 23 / Friday, February 4, 2005 / Notices
Data collection
73.7(h)(1) ..........................................
Amendment to Registration Application.
Notification Form ..............................
Request for Exemption/Exclusion ....
Transfer of Select Agent or Toxin ....
Clinical and Diagnostic Laboratory
Exemption Report.
Request expedited review ................
Documentation of self-inspection .....
Documentation of training ................
Administrative Review ......................
Ensure secure recordkeeping system.
73.19(a)(b) ........................................
73.5 & 73.6 (d-e)/73.3 & 73.4(e)(1) ..
73.16 .................................................
73.5 & 73.6(a)(b) ...............................
73.10(e) .............................................
73.9(a)(5) ..........................................
73.15(c) .............................................
73.20 .................................................
73.17 .................................................
Total ...........................................
Responses
per respondent
Number of
respondents
CFR reference
...........................................................
2
1
700
12
17
350
325
1
1
2
4
1
1
90/60
1
12
17
1,050
1,300
10
350
350
15
350
1
1
1
1
1
30/60
1
2
4
4
5
350
700
60
1,400
........................
........................
........................
7,785
Dated: January 28, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–2140 Filed 2–3–05; 8:45 am]
BILLING CODE 4163–18–P
BILLING CODE 4163–19–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Centers for Disease Control and
Prevention
Centers for Disease Control and
Prevention
Board of Scientific Counselors,
National Center for Health Statistics:
Notice of Charter Renewal
This gives notice under the Federal
Advisory Committee Act (Pub. L. 92–
463) of October 6, 1972, that the Board
of Scientific Counselors, National
Center for Health Statistics, Centers for
Disease Control and Prevention, of the
Department of Health and Human
Services, has been renewed for a 2-year
period through January 19, 2007.
For information, contact Robert J.
Weinzimer, Executive Secretary, Board
of Scientific Counselors, National
Center for Health Statistics, Centers for
Disease Control and Prevention, of the
Department of Health and Human
Services, Metro III, Presidential
Building, 6525 Belcrest Road,
Hyattsville, Maryland 20782, telephone
301/458–4565 or fax 301/458–4025.
The Director, Management Analysis
and Services Office, has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities, for both CDC
and the Agency for Toxic Substances
and Disease Registry.
VerDate jul<14>2003
18:52 Feb 03, 2005
Jkt 205001
Guide to Community Preventive
Services (GCPS) Task Force
In accordance with section 10(a)(2) of
the Federal Advisory Committee Act
(Pub. L. 92–463), the Centers for Disease
Control and Prevention (CDC)
announces the following meeting:
Name: Task Force on Community
Preventive Services.
Times and Dates: 8 a.m.–7 p.m.,
February 16, 2005. 8 a.m.–1 p.m.,
February 17, 2005.
Place: The Hyatt Regency Atlanta, 265
Peachtree Street, Atlanta, Georgia
30303–1294, telephone (404) 577–1234.
Status: Open to the public, limited
only by the space available.
Purpose: The mission of the Task
Force is to develop and publish a Guide
to Community Preventive Services,
which is based on the best available
scientific evidence and current expertise
regarding essential public health and
what works in the delivery of those
services.
Matters To Be Discussed: Agenda
items include: briefings on
administrative information, release of
the Community Guide book,
dissemination of Community Guide
findings and the book, work with the
Campbell and Cochrane Collaborations,
using reviews conducted by external
groups to support Community Guide
PO 00000
Frm 00049
Fmt 4703
Total annual
burden
(in hours)
350
Dated: January 31, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of
the Chief Science Officer, Centers for Disease
Control and Prevention.
[FR Doc. 05–2144 Filed 2–3–05; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Average hourly burden
Sfmt 4703
recommendations, update on
collaborative review of HIV risk
reduction for men who have sex with
men (MSM), possible recommendations
for HIV partner counseling and referral
services (PCRS), reducing the harmful
consequences of trauma among
juveniles, one-on-one interventions and
multi-component media to increase
cancer screening, culturally competent
health care systems, update and
finalizing of recommendation outcomes
for the alcohol reviews.
Agenda items are subject to change as
priorities dictate.
Persons interested in reserving a
space for this meeting should call 404/
498–6180 by close of business on
February 9, 2005.
Contact Person or Additional
Information: Peter Briss, M.D., Chief,
Community Guide Branch, Coordinating
Center for Health Information and
Service, National Center for Health
Marking, Division of Prevention
Research, 1600 Clifton Road, M/S E–90,
Atlanta, GA 30333 (404) 498–6180.
The Director, Management Analysis
and Services Office has been delegated
the authority to sign Federal Register
notices pertaining to announcements of
meetings and other committee
management activities for both the
Centers for Disease Control and
Prevention and the Agency for Toxic
Substances and Disease Registry.
Dated: January 31, 2005.
Alvin Hall,
Director, Management Analysis and Services
Office, Centers for Disease Control and
Prevention.
[FR Doc. 05–2143 Filed 2–3–05; 8:45 am]
BILLING CODE 4163–18–P
E:\FR\FM\04FEN1.SGM
04FEN1
]]>Agencies
[Federal Register Volume 70, Number 23 (Friday, February 4, 2005)]
[Notices]
[Pages 6009-6011]
From the Federal Register Online via the Government Printing Office [www.gpo.gov]
[FR Doc No: 05-2144]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Disease Control and Prevention
[60Day-05-0576]
Proposed Data Collections Submitted for Public Comment and
Recommendations
In compliance with the requirement of Section 3506(c)(2)(A) of the
Paperwork Reduction Act of 1995 for opportunity for public comment on
proposed data collection projects, the Centers for Disease Control and
Prevention (CDC) will publish periodic summaries of proposed projects.
To request more information on the proposed projects or to obtain a
copy of the data collection plans and instruments, call the CDC Reports
Clearance Officer on (404) 371-5976. CDC is requesting an emergency
clearance from OMB regarding this data collection with a 10 day public
comment period. The emergency clearance is based on a revision of this
data collection as a result of a final rule.
Comments are invited on: (a) Whether the proposed collection of
information is necessary for the proper performance of the functions of
the agency, including whether the information shall have practical
utility; (b) the accuracy of the agency's estimate of the burden of the
proposed collection of information; (c) ways to enhance the quality,
utility, and clarity of the information to be collected; and (d) ways
to minimize the burden of the collection of information on respondents,
including through the use of automated collection techniques or other
forms of information technology. To request a copy of these requests,
call the CDC Reports Clearance Officer at (404) 371-5976 or send an e-
mail to omb@cdc.gov. Written comments can be sent to Seleda M.
Perryman, CDC Assistant Reports Clearance Officer, 1600 Clifton Road,
MS-D74, Atlanta, GA 30333 or sent via e-mail to omb@cdc.gov. Written
comments can also be faxed to the CDC Desk Officer, Human Resources and
Housing Branch, Office of Management and Budget at (202) 395-6974.
Written comments should be received within 10 days of this notice.
Proposed Project
Possession, Use, and Transfer of Select Agents and Toxins (OMB
Control No. 0920-0576)--Extension--Office of the Director (OD), Centers
for Disease Control and Prevention (CDC).
The Public Health Security and Bioterrorism Preparedness and
[[Page 6010]]
Response Act of 2002 (Pub. L. 107-188) specifies that the Secretary of
Health and Human Services shall provide for the establishment and
enforcement of standards and procedures governing the possession, use,
and transfer of select biological agents and toxins. The Act specifies
that facilities that possess, use, and transfer select agents register
with the Secretary. The Secretary has designated CDC as the agency
responsible for collecting this information.
CDC is requesting an emergency clearance to allow the continued
collection of this information through the use of five separate forms.
These forms have been revised since the last clearance. This emergency
request will allow CDC to use the revised forms. These forms are: (1)
Application for Registration, (2) Transfer of Select Agent or Toxin
Form, (3) Facility Notification of Theft, Loss, or Release Form, (4)
Clinical and Diagnostic Laboratory Reporting Form, and (5) Request for
Exemption.
The Application for Registration (42 CFR 73.7(d)) will be used by
entities to register with CDC. The Application for Registration
requests facility information; a list of select agents or toxins in
use, possession, or for transfer by the entity; characterization of the
select agent or toxin; and laboratory information. Estimated average
time to complete this form is 3 hours, 45 minutes for an entity with
one principal investigator working with one select agent or toxin. CDC
estimates that entities will need an additional 45 minutes for each
additional investigator or agent. In our regulatory analysis, we have
estimated that 70% of the 350 entities have 1-3 principal
investigators, 15% have 5 principal investigators, and 15% have 10
principal investigators. We have used these figures to calculate the
burden for this section. The revisions to this form were administrative
in nature. Estimated burden for the Application for Registration is
2,191 hours.
Entities may amend their registration (42 CFR, 73.7(h)(1)) if any
changes occur in the information submitted to the HHS Secretary. To
apply for an amendment to a certificate of registration, an entity must
obtain the relevant portion of the application package and submit the
information requested in the package to CDC. Estimated time to amend a
registration package is 1 hour.
The Facility Notification Form (42 CFR 73.19(a), (b)) must be
completed by entities whenever there is theft, loss, or release of a
select agent or toxin. In the revised rules we are now requiring
reporting from exempt entities. Estimated average time to complete this
form is 1 hour.
The Request for Exemption form (42 CFR 73.5 (d), (e) and 73.6 (d),
(e)) will be used by entities that are using select agents or toxins in
investigational new drug testing or in cases of public health
emergency. The revisions to this form were administrative in nature.
Estimated average time to complete this form is 1 hour.
The Transfer of Select Agent or Toxin Form (42 CFR 73.16) will be
used by entities requesting transfer of a select agent or toxin to
their facility and by the entity transferring the agent. CDC revised
the Transfer of Select Agent or Toxin Form by removing the requirement
that entities provide written notice within five business days when
select agents or toxins are consumed or destroyed after a transfer.
Estimated average time to complete this form is 1 hour, 30 minutes.
The Clinical and Diagnostic Laboratory Exemption Report (42 CFR
73.5(a), (b) and 73.6(a), (b)) will be used by clinical and diagnostic
laboratories to notify the HHS Secretary that select agents or toxins
identified as the result of diagnostic or proficiency testing have been
disposed of in a proper manner. In the revised form revisions were made
to clarify that the registered entities required to report can now
retain the agent. Estimated average time to complete this form is 1
hour.
In addition to the standardized forms, this regulation also
outlines situations in which an entity must notify or may make a
request of the HHS Secretary in writing. An entity may apply to the HHS
Secretary for an expedited review of an individual (e.g. Principal
Investigator) by the Attorney General (42 CFR 73.10(e)). To apply for
this expedited review, an entity must submit a request in writing to
the HHS Secretary establishing the need for such action. The estimated
time to gather the information and submit this request is 30 minutes.
CDC has not developed standardized forms to use in the above
situations. Rather, the entity should provide the information as
requested in the appropriate section of the regulation.
An entity may also apply to the HHS Secretary for an exclusion of
an attenuated strain of a select agent or toxin that does not pose a
severe threat to public health and safety (42 CFR 73.3(e)(1) and
73.4(e)(1)). The estimated time to gather the information and submit
this request is 1 hour.
As part of the requirements of the Responsible Official, the
Responsible Official is required to conduct regular inspections (at
least annually) of the laboratory where select agents or toxins are
stored. Results of these self-inspections must be documented (42 CFR
73.9(a)(5)). CDC estimates, that, on average, such documentation will
take 1 hour.
As part of the training requirements of this regulation, the entity
is required to record the identity of the individual trained, the date
of training, and the means used to verify that the employee understood
the training (42 CFR 73.15(c)). Estimated time for this documentation
is 2 hours per principal investigator.
An entity or an individual may request administrative review of a
decision denying or revoking certification of registration (42 CFR
73.20). This request must be made in writing and within 30 calendar
days after the adverse decision. This request should include a
statement of the factual basis for the review. CDC estimates the time
to prepare and submit such a request is 4 hours.
Finally, an entity must implement a system to ensure that certain
records and databases are accurate and that the authenticity of records
may be verified (42 CFR 73.17). The time to implement such a system is
estimated to average 4 hours.
The cost to respondents is their time to complete the forms and
comply with the reporting and recordkeeping components of the Act plus
a one-time purchase of a file cabinet (estimated cost $400) to maintain
records.
Annualized Burden Hours:
----------------------------------------------------------------------------------------------------------------
Total annual
CFR reference Data collection Number of Responses per Average hourly burden (in
respondents respondent burden hours)
----------------------------------------------------------------------------------------------------------------
73.7(d)....................... Registration 350 1 3.75 1,313
Application.
73.7(d)....................... Additional 245 2 45/60 368
Investigators.
73.7(d)....................... Additional 53 4 45/60 159
Investigators.
73.7(d)....................... Additional 52 9 45/60 351
Investigators.
[[Page 6011]]
73.7(h)(1).................... Amendment to 350 2 1 700
Registration
Application.
73.19(a)(b)................... Notification 12 1 1 12
Form.
73.5 & 73.6 (d-e)/73.3 & Request for 17 1 1 17
73.4(e)(1). Exemption/
Exclusion.
73.16......................... Transfer of 350 2 90/60 1,050
Select Agent or
Toxin.
73.5 & 73.6(a)(b)............. Clinical and 325 4 1 1,300
Diagnostic
Laboratory
Exemption
Report.
73.10(e)...................... Request 10 1 30/60 5
expedited
review.
73.9(a)(5).................... Documentation of 350 1 1 350
self-inspection.
73.15(c)...................... Documentation of 350 1 2 700
training.
73.20......................... Administrative 15 1 4 60
Review.
73.17......................... Ensure secure 350 1 4 1,400
recordkeeping
system.
-------------------
Total..................... ................ .............. .............. .............. 7,785
----------------------------------------------------------------------------------------------------------------
Dated: January 31, 2005.
Betsey Dunaway,
Acting Reports Clearance Officer, Office of the Chief Science Officer,
Centers for Disease Control and Prevention.
[FR Doc. 05-2144 Filed 2-3-05; 8:45 am]
BILLING CODE 4163-18-P
